These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21309475)

  • 1. Differential effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation.
    Zhang R; Ran HH; Zhu HL; Chen Q
    J Int Med Res; 2010; 38(5):1617-25. PubMed ID: 21309475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
    Neubauer H; Engelhardt A; Krüger JC; Lask S; Börgel J; Mügge A; Endres HG
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):91-7. PubMed ID: 20410834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
    Claeys MJ; Van Der Planken MG; Michiels JJ; Vertessen F; Dilling D; Bosmans JM; Vrints CJ
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):283-8. PubMed ID: 12032392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Andersson T; Nagy P; Niazi M; Nylander S; Galbraith H; Ranjan S; Wallentin L
    Am J Cardiovasc Drugs; 2014 Jun; 14(3):217-27. PubMed ID: 24677117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
    Chan FK; Ching JY; Hung LC; Wong VW; Leung VK; Kung NN; Hui AJ; Wu JC; Leung WK; Lee VW; Lee KK; Lee YT; Lau JY; To KF; Chan HL; Chung SC; Sung JJ
    N Engl J Med; 2005 Jan; 352(3):238-44. PubMed ID: 15659723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
    Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
    JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
    Diehl P; Olivier C; Halscheid C; Helbing T; Bode C; Moser M
    Basic Res Cardiol; 2010 May; 105(3):379-87. PubMed ID: 19943165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
    Mehta SR; Tanguay JF; Eikelboom JW; Jolly SS; Joyner CD; Granger CB; Faxon DP; Rupprecht HJ; Budaj A; Avezum A; Widimsky P; Steg PG; Bassand JP; Montalescot G; Macaya C; Di Pasquale G; Niemela K; Ajani AE; White HD; Chrolavicius S; Gao P; Fox KA; Yusuf S;
    Lancet; 2010 Oct; 376(9748):1233-43. PubMed ID: 20817281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
    Kasprzak M; Koziński M; Bielis L; Boinska J; Plazuk W; Marciniak A; Budzyński J; Siller-Matula J; Rość D; Kubica J
    Cardiol J; 2009; 16(6):535-44. PubMed ID: 19950090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazole.
    Moceri P; Doyen D; Cerboni P; Ferrari E
    Thromb Res; 2011 Nov; 128(5):458-62. PubMed ID: 21777954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel.
    El-Halabi MM; Zgheib N; Mansour NM; Malli A; Ghaith OA; Mahfouz R; Alam S; Sharara AI
    J Cardiovasc Pharmacol; 2013 Jul; 62(1):41-9. PubMed ID: 23474843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
    Cai J; Wu Q; Fan L; Liu CF; Wang ZG; Sun J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):266-9. PubMed ID: 21038666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.